Atlas Trials

Sung Yong Lee

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sung Yong Lee

RecordFirmDate
A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy (NCT05338619)Sung Yong Lee2022-06-30

Track Sung Yong Lee automatically

Every clearance here is in the API, with alerts when new ones post.